Company intelligence / Profile preview

Matrix Capital Master Fund

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Matrix Capital Management is a prominent investment firm and hedge fund founded in 1999 by David Goel and Paul Ferri. Headquartered in Waltham, Massachusetts, the firm specialized in concentrated, technology-focused investments, with a particular emphasis on life sciences, biotechnology, and artificial intelligence. Matrix was a significant backer of several high-profile biotech companies, including Adaptive Biotechnologies, Zentalis Pharmaceuticals, and Aura Biosciences. In August 2024, the firm announced it would wind down operations and return capital to investors following health issues faced by its founder, David Goel.

Industry: Investors

Beyond the preview

Go deeper on Matrix Capital Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix Capital Master Fund.

Explore the full profile